Your browser doesn't support javascript.
loading
Role of Systemic Factors in Improving the Prognosis of Diabetic Retinal Disease and Predicting Response to Diabetic Retinopathy Treatment.
Mellor, Joe; Jeyam, Anita; Beulens, Joline W J; Bhandari, Sanjeeb; Broadhead, Geoffrey; Chew, Emily; Fickweiler, Ward; van der Heijden, Amber; Gordin, Daniel; Simó, Rafael; Snell-Bergeon, Janet; Tynjälä, Anniina; Colhoun, Helen.
Affiliation
  • Mellor J; Centre for Population Health Sciences, Usher Institute, University of Edinburgh, Edinburgh, Scotland.
  • Jeyam A; Centre for Genomic & Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, Western General Hospital Crewe Road, Edinburgh, Scotland.
  • Beulens JWJ; Department of Epidemiology & Data Science, Amsterdam Public Health Research Institute, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands.
  • Bhandari S; Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland.
  • Broadhead G; Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland.
  • Chew E; Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland.
  • Fickweiler W; Beetham Eye Institute, Joslin Diabetes Center, Boston, Massachusetts.
  • van der Heijden A; Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts.
  • Gordin D; Department of General Practice, Amsterdam Public Health Institute, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands.
  • Simó R; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Department of Nephrology, Helsinki University Hospital, University of Helsinki, Finland.
  • Snell-Bergeon J; Endocrinology & Nutrition, Institut de Recerca Hospital Universitari Vall d'Hebron (VHIR), Barcelona, Spain.
  • Tynjälä A; Clinical Epidemiology Division, Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Colorado.
  • Colhoun H; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Department of Nephrology, Helsinki University Hospital, University of Helsinki, Finland.
Ophthalmol Sci ; 4(4): 100494, 2024.
Article in En | MEDLINE | ID: mdl-38694495
ABSTRACT
Topic To review clinical evidence on systemic factors that might be relevant to update diabetic retinal disease (DRD) staging systems, including prediction of DRD onset, progression, and response to treatment. Clinical relevance Systemic factors may improve new staging systems for DRD to better assess risk of disease worsening and predict response to therapy.

Methods:

The Systemic Health Working Group of the Mary Tyler Moore Vision Initiative reviewed systemic factors individually and in multivariate models for prediction of DRD onset or progression (i.e., prognosis) or response to treatments (prediction).

Results:

There was consistent evidence for associations of longer diabetes duration, higher glycosylated hemoglobin (HbA1c), and male sex with DRD onset and progression. There is strong trial evidence for the effect of reducing HbA1c and reducing DRD progression. There is strong evidence that higher blood pressure (BP) is a risk factor for DRD incidence and for progression. Pregnancy has been consistently reported to be associated with worsening of DRD but recent studies reflecting modern care standards are lacking. In studies examining multivariate prognostic models of DRD onset, HbA1c and diabetes duration were consistently retained as significant predictors of DRD onset. There was evidence of associations of BP and sex with DRD onset. In multivariate prognostic models examining DRD progression, retinal measures were consistently found to be a significant predictor of DRD with little evidence of any useful marginal increment in prognostic information with the inclusion of systemic risk factor data apart from retinal image data in multivariate models. For predicting the impact of treatment, although there are small studies that quantify prognostic information based on imaging data alone or systemic factors alone, there are currently no large studies that quantify marginal prognostic information within a multivariate model, including both imaging and systemic factors.

Conclusion:

With standard imaging techniques and ways of processing images rapidly evolving, an international network of centers is needed to routinely capture systemic health factors simultaneously to retinal images so that gains in prediction increment may be precisely quantified to determine the usefulness of various health factors in the prognosis of DRD and prediction of response to treatment. Financial Disclosures Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Ophthalmol Sci Year: 2024 Document type: Article Affiliation country: Reino Unido Country of publication: Países Bajos

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Ophthalmol Sci Year: 2024 Document type: Article Affiliation country: Reino Unido Country of publication: Países Bajos